Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-Bromo-5-methylthiophene-2-carboxylic acid (3BMT) is a drug that inhibits the enzyme succinate dehydrogenase. Succinate dehydrogenase is an enzyme that catalyzes the conversion of succinate to fumarate in the citric acid cycle, which is a series of biochemical reactions in cellular respiration. 3BMT prevents the formation of acetyl coenzyme A, which is needed for the production of energy in cells. This drug also has a pyrrole moiety that can be oxidized by difluoromethylating it and then reacting with pyrrole to form 2,4-dichloropyrimidine. 3BMT has been shown to inhibit carboxamides such as L-aspartate oxidase and glutamate decarboxylase.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-Methyl-2-phenylthiazole-5-carboxylic acid hydrazide is a potent anticancer agent. It has been shown to inhibit the growth of cancer cells through inhibition of DNA synthesis and protein synthesis, as well as by inducing apoptosis. 4-Methyl-2-phenylthiazole-5-carboxylic acid hydrazide binds to the active site of DNA gyrase, an enzyme that maintains the integrity of bacterial DNA. This binding prevents the formation of an antibiotic-inhibitor complex with the enzyme cell wall synthesis that is required for cell wall biosynthesis, inhibiting protein synthesis and cell division. The antitumor activity was found to be mediated through interactions with pharmacological targets such as butanamide, phenacyl, dioxane, and chlorides. These drugs bind to pharmacophores on tumor cells and are able to penetrate into tumor cells more easily than other drugs. The potent anticancer</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-(Pyridin-2-yl)pyrimidin-4-amine (PPPA) is an antimicrobial agent that is used in the treatment of bacterial infections. It binds to the chloride ion in the cell wall and prevents the formation of a functional pore, causing leakage of cellular contents. PPPA reacts with cyanamide to form 2-(pyridin-2-yl)pyrimidin-4(1H)-one (PPPOH), which is more reactive than PPPA. The reactivity of PPPOH causes damage to the cell's cytoplasmic membrane, leading to cell death. PPPA also reacts with nitro, alkynyl, and alkylaminoalkyl groups, as well as carboxy, cyano, and alkenyl groups on proteins and amino acids. PPPA hydrolyzes phenoxy and cyclohexane rings found in some antibiotics such as tetracycline.</p>

<p>Versatile small molecule scaffold</p>

<p>3-Hydroxy-4-propoxybenzaldehyde is a metabolically stable inhibitor of the enzyme, phenylalanine 4-hydroxylase. 3HPA inhibits the production of phenolic compounds and reduces the risk of cancer. It has been shown to be potently active against human leukemia cells in vitro, but less active against other cell lines. 3HPA is also selective for tumor cells, which may be due to its ability to inhibit DNA synthesis by preventing the formation of n-substituted benzylamino compounds. 3HPA stabilizes DNA and RNA synthesis, which may help prevent tumor growth.</p>